CEO of Relmada Therapeutics, Inc. (NASDAQ:RLMD), Traversa Sergio, sells 5,963 shares worth $209,939
According to Relmada Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:25 PM, company CEO, Traversa Sergio disclosed selling 5,963 shares at a cost of $35.21. At the time of this transaction (Feb 09), this trade was worth $209,939 in total. As of Feb 09, Traversa Sergio now owns 90,704 shares in total worth about $3,170,104.8000000003.
For the last few recent trades made by Relmada Therapeutics, Inc. (NASDAQ:RLMD) CEO, Traversa Sergio, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 3,313 shares at the rate of $35.03 per share. Total worth of this trade was $116,049. Total number of shares owned as of Feb 08 were 96,667
- SEC Form 4 filing: Feb 10: Sold 1,930 shares at the rate of $35.28 per share. Total worth of this trade was $68,097. Total number of shares owned as of Feb 10 were 88,774
- SEC Form 4 filing: Feb 02: Sold 3,178 shares at the rate of $35.08 per share. Total worth of this trade was $111,470. Total number of shares owned as of Feb 02 were 88,874
Posted by
George Daniels
on Wednesday February 10 2021, 10:52 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
